1|10000|Public
40|$|Two years ago, in an {{editorial}} [1] sparked by the revelations from PLoS Medicine and The New York Times ’ <b>intervention</b> <b>in</b> <b>litigation</b> relating to Prempro [2], we wrote that ‘‘the story told in these documents amounts {{to one of the}} most compelling expositions ever seen of the systematic manipulation and abuse of scholarly publishing by the pharmaceutical industry and its commercial partners in their attempt to influence the health care decisions of physicians and the general public. ’ ’ In the first scholarly examination of these documents, published late last year [3], Adriane Fugh-Berman concluded that ‘‘marketing messages in credible journals have almost certainly contributed to widespread use of hormone replacement therapy among millions of women who had no medical indication for the drug’ ’ – a statement that suggests the medical literature had been acting in direct contradiction of the first ethical rule of all physicians, to ‘‘first, do no harm. ’’ Over the past month PLoS Medicine has published three articles that bring new perspectives to the problem of ghostwriting. These perspectives and the possible remedies that two of them offer need serious consideration in light of two recent conferences [4, 5] and other evidence suggesting that, in stark contrast to the protestations of many in the pharmaceutical and medical writing industries, ghostwriting and its larger relation, ghost-management, of the medical literature remain key tactics deployed by pharmaceutical companies, and that current attempts to reduce the practices are not succeeding. The first article, by Simon Stern and Trudo Lemmens [6], takes a novel legal perspective and suggests that legal sanctions could be applied. They argue that a ‘‘guest author’s claim for credit of an article written by someone else constitutes legal fraud’ ’ and that, in addition, ‘‘The same fraud could support claims of ‘fraud on the court ’ against a pharmaceutical company that has used ghostwritten articles in litigation. ’ ’ These are potentially very serious charges that could be laid at the door of ghost and guest authors and their employers. The second article, by medical writer Alastair Matheson [7], takes a critical look at the rules of authorship for medical journals, as laid down by the Internationa...|$|E
50|$|These also {{included}} a rarely permitted <b>intervention</b> <b>in</b> the High Court of Australia {{on behalf of the}} UNHCR as amicus curiae in Minister for Immigration v QAAH. In 2009 he was engaged pro bono from Melbourne as senior counsel <b>in</b> <b>litigation</b> against the Tasmanian Government over conditions in Behavioural Management Unit in Tasmania’s Risdon Prison.|$|R
50|$|In 2007 he {{represented}} Brian Mulroney <b>in</b> <b>litigation</b> with businessman Karlheinz Schreiber. He also represented the former Prime Minister <b>in</b> <b>litigation</b> with the journalist Peter C. Newman.|$|R
2500|$|Stardock {{has been}} {{involved}} <b>in</b> <b>litigation</b> <b>in</b> relation to their business: ...|$|R
50|$|Defended the Republic of Congo <b>in</b> <b>litigation</b> <b>in</b> the United States {{arising from}} {{attempts}} to garnish Congo's oil royalties.|$|R
50|$|In 1886 and 1888, {{the company}} and its former {{management}} were involved <b>in</b> <b>litigation</b> <b>in</b> Montreal concerning debts and possible fraud.|$|R
5000|$|Associate Degree <b>in</b> <b>Litigation</b> and E-Discovery Paralegal Studies ...|$|R
50|$|In Australia RAM, {{can be used}} <b>in</b> <b>litigation</b> post 1996.|$|R
5000|$|... #Subtitle level 2: Examples of Applications of Economics <b>in</b> <b>Litigation</b> ...|$|R
5000|$|Reactions magazine, {{a leading}} {{insurance}} publication, named Edwards Wildman [...] "Best Global Law Firm of the Year" [...] at its Global Awards in September 2012. The firm was also recognized as {{first in the}} US for overall law firm and {{in the areas of}} regulation and insolvency in the US, as well as <b>in</b> <b>litigation</b> <b>in</b> the London market; second in reinsurance in the US and in the London market; and third <b>in</b> <b>litigation</b> <b>in</b> the US and in regulation in Bermuda.|$|R
50|$|RMS Titanic and Premier {{continue}} to be involved <b>in</b> <b>litigation</b> over the matter.|$|R
50|$|Eric Gibbs is {{currently}} participating <b>in</b> <b>litigation</b> against Takeda Pharmaceuticals over association between bladder cancer and the diabetes drug Actos (Pioglitazone), and <b>in</b> <b>litigation</b> against Janssen Pharmaceuticals and Johnson & Johnson over association between male breast {{development and the}} anti-psychotic drugs Risperdal and Invega. Additionally, Girard Gibbs LLP recently filed a class action suit against Volkswagen over its circumvention of federal emissions tests.|$|R
50|$|In a 2012 article, Miles B. Farmer {{wrote that}} one of the {{greatest}} advantages of arbitration is that cases are resolved faster than <b>in</b> <b>litigation.</b> George Padis wrote that the speed of arbitration benefits consumer claimants with small claims, who would be forced to settle for smaller amounts if the business were able to engage in delaying tactics <b>in</b> <b>litigation.</b>|$|R
50|$|He was {{involved}} <b>in</b> <b>litigation</b> with Beecher and Theodore Tilton which was settled in 1872.|$|R
50|$|Legacy for Excellence <b>in</b> <b>Litigation</b> Award, Snyder Center, University of Baltimore School of Law, 2003.|$|R
5000|$|... #Caption: 3OH!3's hand gesture logo that {{resulted}} <b>in</b> <b>litigation</b> from professional wrestler Diamond Dallas Page.|$|R
5000|$|John Marshall Award for Outstanding Achievement <b>in</b> <b>Litigation</b> of the U.S. Department of Justice (1983) ...|$|R
5000|$|Initiate or {{participate}} <b>in</b> <b>litigation</b> challenging {{a governmental}} agency’s rules, regulations, policies, etc. (45 CFR 1612.5(b)) ...|$|R
25|$|Stored-product {{forensic}} entomology {{is often}} used <b>in</b> <b>litigation</b> over insect infestation or contamination of commercially distributed foods.|$|R
50|$|There was a North American Trust Company {{involved}} <b>in</b> <b>litigation</b> as of 1852 in Albany, New York.|$|R
50|$|Yves Bouvier and Russian billionaire Dmitry Rybolovlev, <b>in</b> <b>litigation</b> over art pricing, {{both have}} Mossack Fonseca companies.|$|R
50|$|Stored-product {{forensic}} entomology {{is often}} used <b>in</b> <b>litigation</b> over insect infestation or contamination of commercially distributed foods.|$|R
50|$|<b>In</b> 1494, <b>in</b> <b>litigation</b> {{with the}} heirs of Jacques d'Armagnac, Boffile yields Castres to his brother-in-law, Alain d'Albret.|$|R
50|$|Lead {{counsel for}} five former United States Attorneys General <b>in</b> <b>litigation</b> during the Clinton Impeachment in federal court.|$|R
40|$|This report {{seeks to}} provide an {{overview}} of Congress's ability to participate <b>in</b> <b>litigation</b> before Article III courts. The report is limited to a discussion of Congress's participation <b>in</b> <b>litigation</b> as either a plaintiff (e. g., the party initiating the suit alleging some sort of harm or violation of law) or as a third-party intervener (e. g., a party who is seeking to join litigation already initiated by another plaintiff) ...|$|R
25|$|As of February 28, 2011, Henderson is <b>in</b> <b>litigation</b> {{over the}} Team Quest {{trademark}} with former teammate Matt Lindland.|$|R
50|$|Another LBBW subsidiary, LBBW Luxemburg S.A., {{is engaged}} <b>in</b> <b>litigation</b> against the American bank Wells Fargo as of 2012.|$|R
50|$|As of February 28, 2011, Henderson is <b>in</b> <b>litigation</b> {{over the}} Team Quest {{trademark}} with former teammate Matt Lindland.|$|R
50|$|The Nutter firm claims {{particular}} expertise <b>in</b> <b>litigation</b> (especially land-use litigation), intellectual property, technology, business, {{and real}} estate law.|$|R
50|$|The {{company also}} engaged <b>in</b> <b>litigation</b> over lead mining in Derbyshire, which it {{alleged to be}} {{infringing}} its monopoly.|$|R
50|$|The Development, Discovery, and Use of Computer Support Systems in Achieving Efficiency <b>in</b> <b>Litigation,</b> 79 COLUM. L. REV. 267 (1979).|$|R
50|$|On May 8, 2015, MacLean was retroactively {{reinstated}} by the Department of Homeland Security, but {{the case}} remains <b>in</b> <b>litigation.</b>|$|R
50|$|Other fictitious {{names for}} a person {{involved}} <b>in</b> <b>litigation</b> under English law were John-Noakes, or John Noakes/Nokes and John-a-Stiles/John Stiles.|$|R
5000|$|The {{company has}} engaged <b>in</b> <b>litigation</b> over {{its use of}} phrases like [...] "The Spirit of Cuba" [...] in Italy.|$|R
5000|$|The Canadian Legal Lexpert Directory (Litigation - Public Law, Litigation - Defamation & Media, and <b>in</b> <b>Litigation</b> - Corporate Commercial) ...|$|R
5000|$|Vault: Ranked first <b>in</b> <b>Litigation</b> Boutiques {{category}} <b>in</b> the U.S., 2013; ranked {{fourth in}} Best Law Firms in Texas category, 2013 ...|$|R
